Regenerative Stem Cell Therapy for Stroke in Europe

Last updated: September 28, 2021
Sponsor: University Hospital, Grenoble
Overall Status: Trial Not Available

Phase

2/3

Condition

Stroke

Cerebral Ischemia

Treatment

N/A

Clinical Study ID

NCT02849613
38RC15.337
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, and secondary health problems affecting not only patients but also their families. Building on emerging preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of regenerative cell therapy to improve stroke recovery and patients quality of life.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Hemispheric ischemic stroke (>1.5cm)
  • Inclusion from 1 to 4 days post-stroke
  • NIHSS > or = 7
  • No craniectomy
  • Able to follow a rehabilitation program
  • Modified Rankin scale = 0 before stroke onset

Exclusion

Exclusion Criteria:

  • Coma
  • Severe leucoariosis
  • Previous stroke
  • Active endocarditis, pneumonia, AIDS, active hepatic disease due to HBV or HCV
  • History of cancer
  • Pregnancy, breast feeding

Study Design

Study Start date:
March 01, 2016
Estimated Completion Date:
September 30, 2017

Study Description

RESSTORE European multicentre randomised phase IIb will explore the efficacy (functional recovery) and safety of intravenous infusion of allogenic adipose tissue derived mesenchymal stem cells (ADSC) in 400 stroke patients. Therapeutic effects of ADSCs will be assessed and monitored in patients using clinical rating scales, multimodal MRI and blood biomarkers.

The European regenerative therapy capacities (France, Spain, Finland, United Kingdom and Czech Republic), developed in RESSTORE will cover the full value chain in the field (large scale GMP cell production, clinical testing, biomarkers discovery, understanding of the restoring mechanisms, biobanking...).

Connect with a study center

  • University Grenoble Hospital / EFS

    Grenoble, 38043
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.